Vivo Opportunity, LLC executed the largest insider purchase in the company's history by buying 51,056 shares at $1.56, signaling confidence amidst a recent 7.91% pullback following a 122% surge over the past month.
Price context
The stock is currently trading at $1.455, down 7.91% over the last five days but still up 122.14% over the past month, leaving it 26.52% below its 52-week high of $1.98.
Catalysts to watch
The company is reshaping its strategy through a reverse merger with Mentari Therapeutics announced on May 19, 2026, backed by a $290 million financing round to fund clinical milestones.
Risks
The stock faces elevated volatility, having dropped 7.91% over the last five days, and carries a short interest of 4.07% on a float that suggests limited liquidity relative to the recent surge.
AI-generated context from public data. Not investment advice. Verify before trading.